Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
Teranishi
K
K
Department of Thoracic Surgery, Nagoya University, Japan.
Poston
R S
RS
Reitz
B A
BA
Robbins
R C
RC
D000714:Anastomosis, Surgical; D000818:Animals; D001012:Aorta, Abdominal / Q000473:pathology / Q000601:surgery; D002908:Chronic Disease; D003324:Coronary Artery Disease / Q000473:pathology / Q000517:prevention & control*; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology*; D016572:Cyclosporine / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D016027:Heart Transplantation / Q000473:pathology / Q000502:physiology*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D011183:Postoperative Complications; D051381:Rats; D011912:Rats, Inbred ACI; D011919:Rats, Inbred Strains; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous; D014682:Vena Cava, Inferior / Q000473:pathology / Q000601:surgery
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019331:NG-Nitroarginine Methyl Ester